REFERENCES
1. Pan D, Nazareth J, Sze S, et al. Transmission of monkeypox/mpox virus: A narrative review of environmental, viral, host, and population factors in relation to the 2022 international outbreak. Journal of Medical Virology . 2023;95(2):e28534.
2. Kumar N, Tripathi BN. A serious skin virus epidemic sweeping through the Indian subcontinent is a threat to the livelihood of farmers.Virulence . Dec 2022;13(1):1943-1944. doi:10.1080/21505594.2022.2141971
3. Haller SL, Peng C, McFadden G, Rothenburg S. Poxviruses and the evolution of host range and virulence. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases . Jan 2014;21:15-40. doi:10.1016/j.meegid.2013.10.014
4. Bera BC, Shanmugasundaram K, Barua S, et al. Zoonotic cases of camelpox infection in India. Veterinary microbiology . Aug 26 2011;152(1-2):29-38. doi:10.1016/j.vetmic.2011.04.010
5. Marinaik CB, Venkatesha MD, Gomes AR, Reddy P, Nandini P, Byregowda SM. Isolation and molecular characterization of zoonotic Buffalopox virus from skin lesions of humans in India. International journal of dermatology . May 2018;57(5):590-592. doi:10.1111/ijd.13890
6. Patil DY, George S, Sahay RR, et al. A case of human buffalopox in Malappuram, India: The role of mpox surveillance in 2022. Journal of Medical Virology . 2023;95(2):e28580.
7. Alakunle EF, Okeke MI. Monkeypox virus: a neglected zoonotic pathogen spreads globally. Nature reviews Microbiology . Sep 2022;20(9):507-508. doi:10.1038/s41579-022-00776-z
8. Caillat C, Topalis D, Agrofoglio LA, et al. Crystal structure of poxvirus thymidylate kinase: an unexpected dimerization has implications for antiviral therapy. Proceedings of the National Academy of Sciences of the United States of America . Nov 4 2008;105(44):16900-5. doi:10.1073/pnas.0804525105
9. Yang H, Kim SK, Kim M, et al. Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction. The Journal of clinical investigation . Feb 2005;115(2):379-87. doi:10.1172/JCI23220
10. Junge RE, Duncan MC, Miller RE, Gregg D, Kombert M. Clinical presentation and antiviral therapy for poxvirus infection in pudu (Pudu puda). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians . Sep 2000;31(3):412-8. doi:10.1638/1042-7260(2000)031[0412:CPAATF]2.0.CO;2
11. De Clercq E. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections. Clinical microbiology reviews . Apr 2001;14(2):382-97. doi:10.1128/CMR.14.2.382-397.2001
12. Neyts J, De Clercq E. Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice. Antimicrobial agents and chemotherapy . Jan 2001;45(1):84-7. doi:10.1128/AAC.45.1.84-87.2001
13. Snoeck R, De Clercq E. Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients. Current opinion in investigational drugs . Nov 2002;3(11):1561-6.
14. Grosenbach DW, Honeychurch K, Rose EA, et al. Oral Tecovirimat for the Treatment of Smallpox. The New England journal of medicine . Jul 5 2018;379(1):44-53. doi:10.1056/NEJMoa1705688
15. Broekema FI, Dikkers FG. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies . Aug 2008;265(8):871-9. doi:10.1007/s00405-008-0658-0
16. Romanowski EG, Gordon YJ, Araullo-Cruz T, Yates KA, Kinchington PR. The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model.Investigative ophthalmology & visual science . Jul 2001;42(8):1812-5.
17. Chen F, Chu C, Wang X, et al. Hesperetin attenuates sepsis-induced intestinal barrier injury by regulating neutrophil extracellular trap formation via the ROS/autophagy signaling pathway. Food & function . May 11 2023;14(9):4213-4227. doi:10.1039/d2fo02707k
18. Zaafar D, Khalil HMA, Rasheed RA, Eltelbany RFA, Zaitone SA. Hesperetin mitigates sorafenib-induced cardiotoxicity in mice through inhibition of the TLR4/NLRP3 signaling pathway. PloS one . 2022;17(8):e0271631. doi:10.1371/journal.pone.0271631
19. Kong LN, Lin X, Huang C, et al. Hesperetin derivative-12 (HDND-12) regulates macrophage polarization by modulating JAK2/STAT3 signaling pathway. Chinese journal of natural medicines . Feb 2019;17(2):122-130. doi:10.1016/S1875-5364(19)30014-7
20. Fatriansyah JF, Rizqillah RK, Yandi MY. Molecular Docking and Molecular Dynamics Simulation of Fisetin, Galangin, Hesperetin, Hesperidin, Myricetin, and Naringenin against Polymerase of Dengue Virus. Journal of tropical medicine . 2022;2022:7254990. doi:10.1155/2022/7254990
21. Eberle RJ, Olivier DS, Pacca CC, et al. In vitro study of Hesperetin and Hesperidin as inhibitors of zika and chikungunya virus proteases.PloS one . 2021;16(3):e0246319. doi:10.1371/journal.pone.0246319
22. Paredes A, Alzuru M, Mendez J, Rodriguez-Ortega M. Anti-Sindbis activity of flavanones hesperetin and naringenin. Biological & pharmaceutical bulletin . Jan 2003;26(1):108-9. doi:10.1248/bpb.26.108
23. Kumar N, Chander Y, Kumar R, et al. Isolation and characterization of lumpy skin disease virus from cattle in India. PloS one . 2021;16(1):e0241022. doi:10.1371/journal.pone.0241022
24. Khandelwal N, Chander Y, Kumar R, et al. Antiviral activity of Apigenin against buffalopox: Novel mechanistic insights and drug-resistance considerations. Antiviral research . Sep 2020;181:104870. doi:10.1016/j.antiviral.2020.104870
25. Chander Y, Kumar R, Verma A, et al. Resistance Evolution against Host-directed Antiviral Agents: Buffalopox Virus Switches to Use p38-Upsilon under Long-term Selective Pressure of an Inhibitor Targeting p38-alpha. Molecular biology and evolution . Sep 1 2022;39(9)doi:10.1093/molbev/msac177
26. Khandelwal N, Chander Y, Rawat KD, et al. Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants. Antiviral Research . 2017;144:196-204.
27. Khandelwal N, Chander Y, Kumar R, et al. Antiviral activity of Apigenin against buffalopox: Novel mechanistic insights and drug-resistance considerations. Antiviral Research . 2020;181:104870.
28. Chander Y, Kumar R, Verma A, et al. Resistance evolution against host-directed antiviral agents: Buffalopox virus switches to use p38-ϒ under long-term selective pressure of an inhibitor targeting p38-α.Molecular Biology and Evolution . 2022;
29. Biasini M, Bienert S, Waterhouse A, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic acids research . 2014;42(W1):W252-W258.
30. Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of chemical theory and computation . 2015;11(8):3696-3713.
31. Kumar R, Afsar M, Khandelwal N, et al. Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E.Antiviral research . 2021;189:105056.
32. Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2. 0: New docking methods, expanded force field, and python bindings.Journal of chemical information and modeling . 2021;61(8):3891-3898.
33. Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.Protein engineering, design and selection . 1995;8(2):127-134.
34. López-Blanco JR, Aliaga JI, Quintana-Ortí ES, Chacón P. iMODS: internal coordinates normal mode analysis server. Nucleic acids research . 2014;42(W1):W271-W276.
35. Kumar R, Khandelwal N, Thachamvally R, et al. Role of MAPK/MNK1 signaling in virus replication. Virus research . Jul 15 2018;253:48-61. doi:10.1016/j.virusres.2018.05.028
36. Siddiqui N, Tempel W, Nedyalkova L, et al. Structural insights into the allosteric effects of 4EBP1 on the eukaryotic translation initiation factor eIF4E. Journal of molecular biology . 2012;415(5):781-792.
37. Tomoo K, Shen X, Okabe K, et al. Crystal structures of 7-methylguanosine 5′-triphosphate (m7GTP)-and P1-7-methylguanosine-P3-adenosine-5′, 5′-triphosphate (m7GpppA)-bound human full-length eukaryotic initiation factor 4E: biological importance of the C-terminal flexible region. Biochemical Journal . 2002;362(3):539-544.
38. Marennikova S, Shelukhina E, Shenkman L. Role of the temperature of incubation of infected chick embryos in the differentiation of certain poxviruses according to pock morphology. Acta Virologica . 1973;17(4)
39. Baxby D. Variability in the characteristics of pocks produced on the chick chorioallantois by white pock mutants of cowpox and other poxviruses. Epidemiology & Infection . 1969;67(4):637-647.
40. Ding P, Summers MF. Sequestering the 5’-cap for viral RNA packaging.BioEssays : news and reviews in molecular, cellular and developmental biology . Nov 2022;44(11):e2200104. doi:10.1002/bies.202200104
41. Kumar R, Khandelwal N, Chander Y, et al. MNK1 inhibitor as an antiviral agent suppresses buffalopox virus protein synthesis.Antiviral research . Dec 2018;160:126-136. doi:10.1016/j.antiviral.2018.10.022
42. Donaldson EF, Deming DJ, O’Rear JJ, Naeger LK. Regulatory evaluation of antiviral drug resistance in the era of next-generation sequencing.Biomarkers in medicine . 2015;9(11):1047-51. doi:10.2217/bmm.15.63